BioTelemetry, Inc. (NASDAQ: BEAT) received the Food and Drug Administration's approval for its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch. According to the company, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback